Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience.

about

Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience.

Item

http://www.wikidata.org/entity/Q40104469

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Haematopoietic stem cell trans ...... year single-centre experience.

@en

type

Item

label

Haematopoietic stem cell trans ...... year single-centre experience.

@en

prefLabel

Haematopoietic stem cell trans ...... year single-centre experience.

@en

P1476

Haematopoietic stem cell trans ...... -year single-centre experience

@en

P2093

Annette Trickett

http://www.w3.org/2001/XMLSchema#string

Brynn Wainstein

http://www.w3.org/2001/XMLSchema#string

Clementine David

http://www.w3.org/2001/XMLSchema#string

John B Ziegler

http://www.w3.org/2001/XMLSchema#string

Katie Frith

http://www.w3.org/2001/XMLSchema#string

Richard Mitchell

http://www.w3.org/2001/XMLSchema#string

Susan Russell

http://www.w3.org/2001/XMLSchema#string

Tracey O'Brien

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State

Primary Immune Deficiency Treatment Consortium (PIDTC) report.

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Gene Therapy for the Treatment of Primary Immune Deficiencies.

Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.

Long-term outcomes of fludarabine, melphalan and antithymocyte globulin as reduced-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with primary immunodeficiency disorders: a prospective single center

P304

988-994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JPC.13643

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28752571

http://www.w3.org/2001/XMLSchema#string